Aljawai, Y., Jeong, A., Ramanathan, M., Shah, G., Suh, H., Hiemenz, J., Licht, J., Clark, W., Akard, L., Woolfrey, A., Sukhtankar, D., Cardarelli, P., Caculitan, N., Khouri, J. (2025). An open-label, multi-center Phase 2 study to assess the safety and efficacy of burixafor (GPC-100) and propranolol with G-CSF for the mobilization of hematopoietic progenitor cells in patients with multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-1050